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Abstract
Early entry to HIV care and receipt of antiretroviral therapy improve the health of the individual 
and decrease the risk of transmission in the community. To increase the limited information on 
prospective decisions to enter care and how these decisions relate to beliefs about HIV 
medications, we analyzed interview data from the Never in Care Project, a multisite project 
conducted in Indiana, New Jersey, New York City, Philadelphia, and Washington State. From 
March 2008 through August 2010, we completed structured interviews with 134 persons with no 
evidence of HIV care entry, 48 of whom also completed qualitative interviews. Many respondents 
believed that HIV care entails the passive receipt of medications that may be harmful or 
unnecessary, resulting in reluctance to enter care. Respondents voiced concerns about prescription 
practices and preserving future treatment options, mistrust of medications and medical care 
providers, and ambivalence about the life-preserving properties of medications in light of an 
assumed negative impact on quality of life. Our results support the provision of information on 
other benefits of care (beyond medications), elicitation of concerns about medications, and 
assessment of psychosocial barriers to entering care. These tasks should begin at the time a 
positive test result is delivered and continue throughout the linkage-to-care process; for persons 
unwilling to enter care immediately, support should be provided in nonmedical settings.
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Recent years have seen the advent of increasingly effective treatments for HIV through 
combination antiretroviral therapy (ART).1 The evidence suggests that early treatment, 
accompanied by high adherence, improves long-term health2 and may lower health care 
costs over the patient’s lifetime.3,4 Clinical guidelines have been revised to recommend that 
therapy be started earlier in the course of disease to take advantage of the health benefits that 
earlier initiation confers.5 Recent studies have indicated that universal testing and 
appropriately prescribed ART for HIV-infected persons would not only benefit the 
individual but would substantially decrease HIV transmissions by decreasing HIV viral load 
in the community.6,7 A recent clinical trial, HPTN 052, showed that early initiation of ART 
significantly reduces HIV transmission to a partner.8 For the full benefits of these “test and 
treat” strategies to be realized, HIV-infected persons must enter care and take ART as 
prescribed before they experience symptoms.9 However, information on acceptance of ART 
in developed countries is limited, particularly among HIV-infected persons who feel well 
and are not already in care.
Although many researchers and clinicians recognize the advantages of timely entry to care 
and acceptance of ART, evidence suggests that some HIV-infected persons may not share 
these beliefs or may place greater importance on perceived disadvantages. For example, 
studies have documented reluctance to take ART and fears about medication side 
effects.10–17 However, because almost all studies have focused on HIV-infected persons 
already engaged in medical care, little is known about how medication-related factors 
influence prospective decisions to enter care.18,19 An important exception is a recent study 
by Pollini and colleagues20 who found that, compared to those in care, persons who had 
never initiated HIV care were more likely to mistrust HIV medications and health care 
providers.
To explore this issue, we reviewed structured and qualitative interview data from the Never 
in Care (NIC) Project: HIV-infected adults who were aware of their infection but had never 
received HIV medical care were asked about their perceptions of HIV medical care and 
barriers to entering care. Although other barriers to entering care were cited (e.g., financial, 
not wanting to think about or disclose HIV status, depression), a prominent theme that 
emerged from qualitative interview data was an equation of HIV care with medications and 
strong concerns about taking HIV medications, resulting in a reluctance to enter care. To 
better understand the mechanisms through which these concerns about medications serve as 
a barrier to care, we describe NIC respondents’ perceptions of the disadvantages and 
advantages of entering HIV medical care and accepting treatment and explore how beliefs 
about medications informed respondents’ ideas about care.
Methods
NIC was a multisite project conducted in Indiana, New Jersey, New York City, Philadelphia, 
and Washington State during 2008–2010. NIC methods have been described in detail 
elsewhere,18,21 but in brief the mixed-method design consisted of a 30-min structured, face-
to-face interview in all five project areas and additional 60-min qualitative interviews in 
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Indiana, Philadelphia, and Washington State. NIC respondents were sampled from the 
Enhanced HIV/AIDS Reporting System (eHARS), a population-based HIV surveillance 
system. NIC-eligible persons had received, and acknowledged, a diagnosis of HIV infection 
at least 90 days before sample selection; were at least 18 years old; spoke English; resided in 
the project area; and had not received HIV medical care. Failure to receive HIV medical 
care was initially determined by lack of CD4 T-lymphocyte or HIV viral load laboratory test 
reports to eHARS and later confirmed with participants during recruitment and interview. 
Informed consent was obtained from all respondents. NIC design and instruments were 
approved by the Institutional Review Boards (IRBs) of the Centers for Disease Control and 
Prevention and participating state or local health departments.
A structured questionnaire was used in all five project areas. This 30-min interview 
collected information on demographics, barriers to entering HIV care, use of complementary 
and alternative medicines, and interactions with general medical providers.
In Indiana, Philadelphia, and Washington State, a maximum of 25 respondents per area were 
recruited for an additional, qualitative interview. Most (79%) interviews were recorded by 
using a digital audio recording device and transcribed verbatim. For 21% of interviews, the 
interviewer took detailed handwritten notes because respondents refused to be recorded or 
the equipment failed. An interviewer observation form was used to document supplementary 
information (e.g., pertinent body language or facial expressions) that was not captured in the 
audio recording.
Six study researchers developed a qualitative interview codebook containing structural and 
thematic codes using a standardized iterative process.22 Differences were resolved through 
discussion and when needed, modification of coding criteria. Two researchers then 
independently coded the qualitative interview transcripts by using NVivo version 8 (QSR 
International, Victoria, Australia), averaging 98% intercoder reliability. We used SAS, 
version 9.3 (SAS Institute, Inc., Cary, NC), to analyze the structured interview data.
Results
Characteristics of respondents
From March 2008 through August 2010, 353 of 1556 (23%) persons with no evidence of 
HIV care entry were located and contacted. We completed structured interviews with 134 
respondents (38% of those contacted and 9% of the total sample), 48 of whom also 
completed qualitative interviews. Of the structured-interview respondents, 76% were male, 
52% were aged 18–34, 77% were of a race/ethnicity other than white (non-Hispanic or 
Latino), and 60% had a high school education or less (Table 1). Large proportions of 
respondents had low annual incomes, were homeless, and lacked continuous health coverage 
during the past 3 months. The results of χ2 tests of association indicated no significant 
demographic differences between structured-interview respondents and qualitative-interview 
respondents (test statistics not shown).
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Among Those Who have Never Been in HIV Care, What Characterizes Persons 
with Concerns about HIV Medications?—Of the 128 NIC respondents who completed 
a structured interview and provided information on barriers to recent care entry, 34 (27%) 
said they had not received HIV medical care during the past 3 months because they believed 
the medicines would do more harm than good or would be unpleasant. In terms of 
demographic variables, respondents who cited medication-related barriers to entering care 
did not differ significantly from respondents who did not cite medication-related barriers 
(Table 2). Although these differences were not statistically significant, those with 
medication-related barriers were somewhat more likely to be a race/ethnicity other than 
white (non-Hispanic or Latino), and less likely to have a mode of HIV exposure related to 
male–male sexual contact and have continuous health-care coverage.
Structured-interview respondents with medication-related barriers to entering care were 
significantly more likely to say they had not received HIV medical care during the past 3 
months because they did not like or trust health care workers (41% versus 6%, p < 0.001). 
They were also significantly more likely to have used complementary or alternative 
medications or self-care (e.g., diet, exercise, rest) to treat their HIV infection (68% versus 
38%, p < 0.01). When respondents who reported a usual place for medical care were asked 
about their interactions with general medical providers, those with medication- related 
barriers were less likely than those without medication-related barriers to say they felt they 
had a “personal health care provider” (44% versus 76%, p = 0.11). This difference was not 
statistically significant and may have been limited by the small number of respondents.
Qualitative interview
How is HIV Medical Care Perceived among Persons with HIV Who have Never 
Been in Care?—To understand the preconceptions that qualitative-interview respondents 
had about HIV care, we asked, “What have you heard about HIV care?” Because none of 
these respondents had ever received care for HIV, their preconceptions stemmed from their 
experiences with non-HIV medical care, beliefs about medications and medical providers, 
cultural and media influences, and the experiences of family members, friends, and others in 
their community.
Care means medications
Although some respondents said they had not heard anything about HIV care or mentioned 
their perception that care is expensive, 67% mentioned medications when asked what they 
had heard about care. A typical response was “There’s a lot of medicines that go along with 
it [care], and a lot of tests.” Many believed that taking medications was an inevitable part of 
being in care for HIV. As one respondent phrased it, “The first thing the doctor wanna do is 
give you some kinda pills or somethin’. And then they have to give you a pill because of 
[what] that pill ain’t doin…” Many respondents were hesitant to enter care because of their 
feelings about taking medication, for example, “When you say medical care, the only thing I 
keep thinkin’ about is medication. And I’m like, I don’t know if I need medication.” When 
discussing their decision not to enter HIV care, some expressly stated their aversion to 
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taking medications, such as this respondent, who stated “Anything…that has to do with pills 
I just…reject. I don’t like it, at all.”
A few respondents recognized that one might not have to take medications for HIV, at least 
not immediately. These respondents expected that if they entered care, doctors would 
perform “tests” and inform them whether they should take medications. As one respondent 
said when describing his posttest counseling session, “They told me that [long pause] I need 
to see my doctor and get all of my, I think that’s what she was talkin’ about, the tests I need 
to be takin’ to see where I’m at with my immune system.”
Preference for alternatives to medical care
Some respondents mentioned preferences for treating their HIV infection with alternative 
forms of care. As one respondent put it, “I’m not really—not too big on conventional 
medicine.” Others mentioned preferences for specific alternative treatments, such as herbs, 
vitamins, or other remedies. One respondent said, “My whole philosophy is [that] if I can do 
something like through herbs, through drinking some tea, or an old family remedy or 
something like that, I would do that in a heartbeat before I take any type of medication.” 
During the interview, respondents brought up various forms of self-care—such as eating 
more nutritious foods, exercising, and getting adequate rest—as a means of avoiding 
traditional HIV medical care. One respondent expressed it this way, “Deep down I still 
wanted, you know, I was still wondering if there was something that I could do from the 
time that I tested positive… onwards…that would probably help me keep myself more 
healthy and just go on with normal life.”
How are Beliefs about HIV Medications Related to Perceptions of 
Disadvantages and Advantages of HIV Care?—Among qualitative interview 
participants, 17 (38%) stated in the structured interview that they had not received HIV 
medical care during the past 3 months because they believed the medicines would do more 
harm than good or would be unpleasant. In the qualitative interview respondents were asked, 
“What are some disadvantages to getting into HIV medical care?” and “What are some 
advantages to getting into HIV medical care?” Because many respondents perceived 
medications as integral to HIV care, ideas about the effects of HIV medications were 
frequently mentioned when respondents discussed the disadvantages and advantages of 
entering care. Almost half of qualitative interview respondents (48%) expressed concerns 
about taking medications. Four broad themes emerged: concerns about prescription 
practices, distrust of medications and medical providers, concern that medications may 
cause more harm than good, and the belief that medications may prolong life.
Concerns about prescription practices
One perceived disadvantage to entering care stemmed from concerns about prescription 
practices. Some expressed worry about starting HIV medications too early in the course of 
their illness. These respondents believed that doing so might adversely affect their long-term 
health or result in the need to take more toxic medications later. Respondents feared that 
starting medications too early would cause them to feel ill at a time when they had no overt 
manifestations of HIV infection. As one respondent put it, “I’ve heard that…the medications 
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start off weaker and then the virus becomes accustomed to that medication. So as the longer 
you have it, the more strong the medication’s gonna be. Probably the more sick you’re 
gonna feel.” One respondent justified his decision to delay taking medications by describing 
what he expected would happen in the future if he started taking HIV medications too soon:
Maybe I was receiving it and really didn’t need it…at the time…I’m getting it but 
really don’t need it…right away. [Maybe] I used it too early or something…. 
Getting started on meds and it might have been too early for me to get started on 
meds. And I was doing just fine. And then I got on the meds and then I was getting 
sicker, or I started getting really, really, really sick.
Another concern about prescription practices centered on receiving ineffective medications. 
For example, one respondent expected that if he got into care, his doctors might have to try 
out a variety of medications until they found one that was effective and that some of those 
ineffective medications might have a negative effect on his health. Some respondents were 
apprehensive about medical or pharmacy errors that could result in receipt of the wrong 
medication:
I’m skeptical because I’m like, “Okay, a doctor could say this and give me the 
wrong medicine.” You know, it happens. It’s happening even at my job. Somebody 
gave my coworkers the wrong medicine. They could have died if they didn’t catch 
it in time. I’m like, I’m scared of medicine.
Distrust of medications and medical providers
Some participants’ concerns about appropriate treatment appeared to arise from a general 
distrust of medications and health care providers. A number of respondents believed that 
providers do not know the true effects of HIV medications and expressed doubt about 
whether HIV medication would actually improve one’s health. One respondent said, “I don’t 
know what it’s gonna do. I don’t know if it’s gonna help or…I…haven’t seen any proof…as 
far as the…pills is concerned, I don’t know if it…really helps.” Some respondents voiced 
suspicions that HIV medications are intended to harm their health. One respondent 
expressed it this way:
I don’t know who, who make these medicines… I just don’t feel comfortable takin’ 
it because I don’t… I really think it’s designed to kill you….people told me that 
people’s on the medicine, they was on the medication, they died anyway….Or they 
died faster. And then they was, they got sicker… So you know… that’s all the 
things I don’t wanna have to go through. I guess that’s part of the reason why I 
never took the medication ‘cause I really think it’s designed to kill you faster.
Part of the suspicion about the ill effects of HIV medications concerned beliefs that 
providers prescribe medications that are experimental and that a person who accepts 
medications is accepting being treated as a “guinea pig.” These sentiments were sometimes 
compounded by a sense that the health care provider is not treating the person, but treating 
the illness, as in this response:
I think doctors are set in their ways some. I can’t judge ‘em all. Say the doctor says 
“I know what I’m doin’. I gave this medicine to so many people, it’s workin’ for 
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them…” …Or I, I would always wonder for, “Are you doin’ it because of your 
experience or are you givin’ me this medicin—medicine because… of what’s goin’ 
on in my body?” …Cause I think the doctors sometime they over, they know it all, 
…you know. They’re dead set in their, in their theory…and that’s it….And I’m not 
sayin’ all of ‘em, but…I want somebody to really know me, what, what’s goin’ on 
in here. I don’t trust nobody, that’s the issue, right there. [laugh] Because…I don’t 
wanna be a guinea pig either….And that’s all it is right now, what I’m reading is 
that they’re just tryin’ this medicine, see if it works with this medicine, …And I’m 
like, they don’t even know. And I’ve read where people are tryin’ this to see if it 
works. It’s workin’ right now but they don’t know what the outcome is….I’m like, 
that’s a guinea pig….I don’t wanna be a guinea pig.
Concern that medications may cause more harm than good
Many respondents echoed the concern that HIV medications may harm health and 
considered it a major disadvantage to receiving care. Many expressed concerns about side 
effects, which were described in terms of feeling “sick.” One respondent expressed fear that 
if he got into care, he would “ …just pretty much be curled up in bed because of the 
medication.” Another respondent stated the idea as follows:
I don’t want medication for HIV….I’d had to be proven…[laugh] ‘Cause I’d, it just 
scares me to think that I’m gonna be more miserable than I am today. And I’m not 
even miserable right now…And you take a pill and it makes you worse than you 
was yesterday….And I feel great today.
For some respondents, fears about feeling sick as a result of taking medications overruled 
concerns about illness or death; that is, they believed that their quality of life would be 
compromised even if the medications would allow them to live longer. One respondent put it 
this way:
…eventually you gonna die anyway. And that’s how I feel, that if I’m gonna die 
I’m not gonna die with these doctors, you, you know, givin’ me pills and stuff. I’d 
rather die on my own instead of, you know…I’m gonna die anyway.
Some thought that in addition to making them feel sick, the medications would cause them 
physical harm. One respondent thought that HIV medications would “mess with, you know, 
the levels, with your body, your nervous system, and all that.” Some believed that their 
bodies would “reject” HIV medications or that HIV medication would “shorten my 
lifespan.” The idea that HIV medication would cause side effects was based on personal 
opinion and the experience of other HIV-infected persons in their lives. One respondent 
described what he learned from his brother-in-law:
Respondent: ’Cause I heard, I heard you get, you can get sick, like, off the medicine they 
give you.
Interviewer: Who told you that?
Respondent: My brother-in-law that’s has HIV.
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Interviewer: Okay. What is, what does he tell you about HIV meds?
Respondent: Not a lot. He say he barely take ’em. And his doctor was mad at him…
The belief that medications may prolong life
When describing perceived advantages to entering HIV medical care, some respondents said 
it might help a person live longer.
I…I have heard that it’s gotten better. There’s…medications that…prolongs your life. I 
thought when you, this HIV thing and next thing you know you can prepare to die. It don’t 
seem like it’s, it’s like that anymore. I think about Magic Johnson when he made the 
announcement, basketball player….and…the type of care that he got or whatever medication 
he was on has preserved him. I mean, from what I see, he’s, you know, he’s in pretty good 
health.
However, as stated above, quality of life was sometimes mentioned in conjunction with the 
life-prolonging effects of HIV medications. The following is one respondent’s expression of 
this concern:
I guess they can prolong it, it can pro—they might be prolong your life…but [long pause] 
even with some people that I have talked to…they take the medicine, some of ‘em do take 
medicine. But they feel miserable! You know? So. I don’t—I don’t know, I, I just don’t 
know. I, I hear though that you can live a, a long time being HIV…positive.
Because respondents were specifically asked about perceptions of advantages to care, some 
said their descriptions of the positive effects of medications were based on things they had 
been told but qualified these statements by saying that they were not sure whether they 
believed them.
Respondent: You know, that’s what they, they tell, you know, is, I guess…When you get 
on the medication and, you know, it can be designed to help you out…as far as your 
antibodies or whatever in your system…It keeps you, is s’posed to keep you stronger, 
basically. I mean, like I said, I dunno if any of that is true, but you know….I dunno, I really 
dunno what to say as far as that…
Interviewer: Okay. And when you’re saying “they” you’re referring to the medication?
Respondent: Yes. When I say “they” I’m talkin’ about like the doctors and the people who 
talk to you.
Discussion
In this sample of HIV-infected persons who had never entered HIV care, reluctance to enter 
care was influenced by reluctance to take medications (informed by distrust of medical care 
providers), and alternatives to conventional medical care were preferred, the combined 
effect of which may have been to deter respondents from entering HIV care. As increasing 
numbers of clinicians endorse early treatment with ART, this finding cautions us that a 
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return to a “Hit early, hit hard” message may deter a significant proportion of HIV-infected 
persons from entering HIV care. Almost one third of our structured-interview respondents 
said that concerns about medications had kept them from accessing care during the past 3 
months, and almost half of qualitative-interview respondents expressed concerns about 
taking medications.
For persons with these concerns, the other benefits of HIV care (e.g., monitoring immune 
system function through laboratory tests, access to ancillary services) should be emphasized. 
In addition, messages to these patients should challenge the idea that HIV care entails the 
passive acceptance of medicines and reframe entering care as a way of taking control and 
being proactive about one’s health through a partnership with a supportive care team. Most 
important, this communication should begin at the time a positive test result is delivered. For 
persons who are unwilling to immediately enter HIV care, this communication should 
continue in supportive nonmedical settings (e.g., HIV/AIDS service organizations, peer 
support groups), since it may take some time for newly diagnosed persons to accept their 
diagnoses.23 After linkage to and engagement in care has been established, individual 
decisions about whether to begin ART can then be made with full knowledge of clinical 
status and accurate information about the risks and benefits of treatment.
Although NIC respondents had not entered HIV care, many perceived care as having several 
disadvantages and few advantages. Respondents voiced concerns about prescription 
practices in terms of receiving appropriate treatment and preserving future treatment 
options, mistrust of medications and medical providers, a sense that medications do more 
harm than good, and an ambivalence toward the life-preserving properties of medications in 
light of an assumed negative impact on quality of life. The respondents who had medication-
related barriers to entering care were more likely to mention dislike and mistrust of health 
care workers, and they were more likely to use complementary and alternative medications 
and self-care to treat their HIV infection.
Among patients who have entered HIV care, fear of side effects, mistrust of medications and 
health care workers, concerns about the effects of medications on quality of life, and a 
preference for alternative medicine and self-care have been associated with lower 
acceptance of ART,11,13–17,24–26 although at least one study found no association between 
conspiracy beliefs and access to care.27 However, research on the role of mistrust of 
medications and health care workers as barriers to entering care has been limited. Negative 
feelings about medications, a preference for self-care over medications, and distrust of 
health care providers have been found to be barriers to care among those who have dropped 
out of care.10 In studying a sample of HIV-infected women who had entered care, Raveis 
and colleagues23 found that negative attitudes toward health care providers were associated 
with delayed entry to HIV care. A recent quantitative study by Pollini and colleagues20 
found that negative ideas about medications and health care providers are common among 
HIV-infected persons who have not entered care, although these factors were not associated 
with being in care once other factors were considered. In a longitudinal study of a small 
number of gay men who had not entered HIV care, researchers found that reluctance to 
receive ART, concerns about side effects, and mistrust of medical care providers affected 
engagement in care.12 These factors, along with a preference for traditional healers rather 
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than medical staff, were associated with suboptimal health care utilization among HIV-
infected Zambians.26 Our analysis supports the limited work in this area in that it also finds 
that concerns about medications and health care providers are common, and extends it by 
articulating the pathways through which fears about medications are related to decisions to 
not enter care.
Our results suggest that to improve linkage to care among persons who have concerns about 
HIV medications, time should be set aside during the delivery of the positive test result to 
describe the care process and explain that care also includes prevention measures and other 
services to ensure the well-being of patients. Staff trained in conducting psychosocial 
evaluations should ask questions about perceptions of HIV medications, use of 
complementary and alternative therapies, and trust in the health care system and health care 
workers. Information on current ART regimen options, the risks and benefits of ART, and 
ART side effects should be provided, but patient concerns should be taken seriously and 
discussed in a manner that encourages reflection.14 These discussions should include a full 
assessment of the patient’s values and sociocultural context as they relate to HIV care.17
Although information about care and medications may be most accurately communicated by 
a medical provider, persons with negative perceptions of HIV medications may never enter a 
care relationship and therefore never have the opportunity to receive this information. In 
addition, as the experiences of NIC respondents indicate, they may not trust medical 
providers and thus prefer alternative therapies to information from the medical 
establishment. Distrust of health care institutions and systems has been found to affect the 
utilization of health care28–30 and may resonate more among people of color,31–34 who 
accounted for most of the new diagnoses of HIV infection in the United States in 2009.35 
Respondents who did not describe themselves as white were somewhat more likely to have 
medication-related barriers to entering HIV care. Because NIC respondents’ ideas about 
HIV care were derived from their experiences in the community, it may be more effective to 
confront their negative perceptions through community-based interventions. Programs 
should consider peer-based and patient navigation strategies that use active referrals, which 
have proved effective in improving linkage to care and care utilization.36–39 Ongoing 
support and outreach in nonmedical settings may also facilitate linkage to, and engagement 
in, care for persons with concerns about medications.
This study has certain limitations. Our sample was drawn from five health department 
jurisdictions, but we were not able to contact a large proportion of potentially eligible 
persons. In addition, half of all interviews (50% of structured and 52% of qualitative) were 
conducted in one jurisdiction, Indiana. Compared to structured participants, a higher 
percentage of qualitative interview participants reported they had not received HIV medical 
care during the past 3 months because of medication concerns (38% versus 27%). Therefore, 
our findings may not represent all HIV-infected persons in the United States who have not 
received HIV care. However, the findings illustrate the beliefs and perceptions of some 
persons who have received a diagnosis of HIV infection but who have never been in care—
an understudied population. Another potential limitation is that because of logistical 
constraints, all qualitative interviews were conducted with English-speaking respondents. In 
addition, most respondents were male; however, the proportion of female NIC respondents 
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(23%) is similar to the proportion of women in the United States who received a diagnosis 
of HIV infection in 2009 (24%).35
Our results indicate that medication concerns may be barriers to HIV care for a substantial 
proportion of persons who do not enter care after receiving a diagnosis of HIV infection. We 
suggest that such concerns be elicited and that psychosocial barriers to entering care be 
assessed at the time of delivery of a positive test result and throughout the linkage-to-care 
process, followed by support and outreach in nonmedical settings to accommodate persons 
who are unwilling to enter care immediately. Building relationships of support and trust with 
nonmedical personnel may be the first step toward empowering HIV-infected persons to 
establish control of their medical care and make informed decisions about treatment.
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Table 1
Characteristics of Never in Care Respondents, 2008–2010
Structured interview
respondents (n = 134)
Qualitative interview
respondents (n = 48)
Characteristic No. % No. %
Gender
  Male 100 76 36 75
  Female 31 23 11 23
  Transgender <5 1 <5 2
Age (years)
  18–34 70 52 23 48
  ≥35 64 48 25 52
Race/ethnicity
  Other than white (non-Hispanic or Latino) 98 77 34 76
  White (non-Hispanic or Latino) 30 23 11 24
Education
  ≤ High school diploma 79 60 28 58
  > High school diploma 52 40 20 42
Mode of HIV exposure was male–male sexual contact 66 49 22 46
Sexual orientation
  Homosexual 54 41 17 35
  Heterosexual 60 45 23 48
  Bisexual 18 14 8 17
Annual income ≤ $10,000 (adjusted for number of dependents) 64 54 22 51
Currently unemployed 68 52 23 48
Homeless, past 3 months 24 18 11 23
Lack of continuous health insurance or coverage, past 3 months 93 70 34 71
Cited medication concerns as a reason for not entering HIV care, past 3 months 34 27 17 38
Interview site
  Indiana 67 50 25 52
  New Jersey 13 10 — —
  New York City, NY 29 22 — —
  Philadelphia, PA 14 10 12 25
  Washington 11 8 11 23
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